Paul David C

Director, Executive Chairman, 10% Owner, Chief Executive Officer · SEC CIK 1555391
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$218.55M
18 trades
Net flow
−$218.55M
Net selling
Total filings
34
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Dec 10, 2025 ΔOwn +132%
+$877.3K
34,375 sh @ $26
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Nov 20, 2024 ΔOwn NEW
+$627.6K
26,042 sh @ $24
GMED
Conversion Paul David C · Director, Executive Chairman, 10% Owner · Conversion · filed Sep 26, 2018 ΔOwn NEW
+$0
748,845 sh
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Sep 26, 2018 ΔOwn −100%

Paul David C sold $40.96M of GMED, trimming their stake 100%.

−$40.96M
748,845 sh @ $55
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Sep 26, 2018 ΔOwn −100%

Paul David C sold $32.72M of GMED, trimming their stake 100%.

−$32.72M
605,871 sh @ $54
Advertisement
GMED
Conversion Paul David C · Director, Executive Chairman, 10% Owner · Conversion · filed Sep 26, 2018 ΔOwn NEW
+$0
101,320 sh
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Sep 26, 2018 ΔOwn −100%

Paul David C sold $16.13M of GMED, trimming their stake 100%.

−$16.13M
298,647 sh @ $54
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Sep 26, 2018 ΔOwn −100%

Paul David C sold $5.47M of GMED, trimming their stake 100%.

−$5.47M
101,320 sh @ $54
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Jul 19, 2018 ΔOwn −1.1%

Paul David C sold $362.2K of GMED, trimming their stake 1%.

−$362.2K
6,841 sh @ $53
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −11%

Paul David C sold $3.78M of GMED, trimming their stake 11%.

−$3.78M
72,938 sh @ $52
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −4.1%

Paul David C sold $1.51M of GMED, trimming their stake 4%.

−$1.51M
29,066 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +1.7%
+$90.1K
18,461 sh @ $5
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −1.7%

Paul David C sold $956.4K of GMED, trimming their stake 2%.

−$956.4K
18,461 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +1.7%
+$219K
18,461 sh @ $12
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +1.7%
+$196.8K
18,461 sh @ $11
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +1.4%
+$230.1K
15,000 sh @ $15
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −1.4%

Paul David C sold $777.1K of GMED, trimming their stake 1%.

−$777.1K
15,000 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +4.5%
+$625.9K
48,000 sh @ $13
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −4.3%

Paul David C sold $2.49M of GMED, trimming their stake 4%.

−$2.49M
48,000 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +5.6%
+$1.44M
60,000 sh @ $24
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −5.3%

Paul David C sold $3.11M of GMED, trimming their stake 5%.

−$3.11M
60,000 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +9.2%
+$2.38M
98,958 sh @ $24
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −8.4%

Paul David C sold $5.13M of GMED, trimming their stake 8%.

−$5.13M
98,958 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +3.8%
+$1.04M
40,625 sh @ $26
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −3.6%

Paul David C sold $2.1M of GMED, trimming their stake 4%.

−$2.1M
40,625 sh @ $52
GMED
Option exercise Paul David C · Director, Executive Chairman, 10% Owner · Option exercise · filed Apr 30, 2018 ΔOwn +4.1%
+$1.15M
43,750 sh @ $26
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −3.9%

Paul David C sold $2.27M of GMED, trimming their stake 4%.

−$2.27M
43,750 sh @ $52
GMED
Sell Paul David C · Director, Executive Chairman, 10% Owner · Open-market sale · filed Apr 30, 2018 ΔOwn −34%

Paul David C sold $18.82M of GMED, trimming their stake 34%.

−$18.82M
363,284 sh @ $52
GMED
Sell Paul David C · Director, Chief Executive Officer, 10% Owner · Open-market sale · filed Mar 20, 2015 ΔOwn −31%

Paul David C sold $12.37M of GMED, trimming their stake 31%.

−$12.37M
494,921 sh @ $25
GMED
Sell Paul David C · Director, Chief Executive Officer, 10% Owner · Open-market sale · filed Mar 20, 2015 ΔOwn −48%

Paul David C sold $35.68M of GMED, trimming their stake 48%.

−$35.68M
1.43M sh @ $25

Frequently asked questions

How is Paul David C's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Paul David C's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.